tailieunhanh - The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

Đang chuẩn bị liên kết để tải về tài liệu:
The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

Xuân Hương 59 11 pdf

Fertility sparing surgery has been extensively performed among patients with borderline ovarian tumors due to their age and favorable prognosis. Nevertheless, the prognosis and obstetric outcomes in these patients remain uncertain. | The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients 40 years old with borderline ovarian tumors

Đang chuẩn bị liên kết để tải về tài liệu:
The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors

Evaluation of the impact of dyke on the practice of using plant protection chemicals and the environment impact quotation index of rice cultivation areas in Thap Muoi, Dong Thap province

Long - term impact of biogas production on soil organic carbon storage

Socio economic impact of lock down due to Covid-19

Analysis of the impact of high oil prices on the global economy

Study on impact forces of the underwater cavity projectile

An investigation on the impact of institutional environment on firm growth in Vietnam

Summary of Doctoral thesis: Impact of investment in developing infrastructure of industrial zones on attracting investment in industrial zones in Binh Dinh province

Thesis summary: Impact of microcredit on the income of poor households in the Southeast Region

Accounting undergraduate Honors theses: How does music consumption impact the music industry and benefit artists?

Summary of PHD thesis: The impact of CNY/USD exchange rate to vietnamese macroeconomic factors

Đang chuẩn bị liên kết để tải về tài liệu: The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors